https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-kyowa-kirin-limited-tostran-testosterone-2-percent-gel-el-23-a-slash-33
Brief description of the problem
Kyowa Kirin Limited has notified MHRA that the priming instructions in the current PIL for Tostran 2% gel require...